Related references
Note: Only part of the references are listed.Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
Vipul Kumar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants
Gideon A. Gyebi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Natural products may interfere with SARS-CoV-2 attachment to the host cell
Abdo A. Elfiky
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12)
Zijing Ruan et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Presumed Asymptomatic Carrier Transmission of COVID-19
Yan Bai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
Qi Kong et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
Yong-Zhen Zhang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Yan Gao et al.
SCIENCE (2020)
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt et al.
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Traditional Chinese Medicine treatment of COVID-19
Jia Xu et al.
COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE (2020)
Convalescent serum lines up as first-choice treatment for coronavirus
Cormac Sheridan
NATURE BIOTECHNOLOGY (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study
Julia del Amo et al.
ANNALS OF INTERNAL MEDICINE (2020)
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer et al.
CELL (2020)
Bioactive natural compounds against human coronaviruses: a review and perspective
Yanfang Xian et al.
ACTA PHARMACEUTICA SINICA B (2020)
The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19
Dongdong Wang et al.
PROCESSES (2020)
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Qiangzhe Zhang et al.
NANO LETTERS (2020)
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost et al.
NATURE MEDICINE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good
Paul E. Gray et al.
PHARMACOLOGICAL RESEARCH (2020)
Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
Qinhai Ma et al.
PHARMACOLOGICAL RESEARCH (2020)
Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)
Yu-Feng Huang et al.
PHARMACOLOGICAL RESEARCH (2020)
Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
Ruocong Yang et al.
PHARMACOLOGICAL RESEARCH (2020)
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
Dan Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Effects of four bamboo derived flavonoids on advanced glycation end products formation in vitro
Man-yu Lan et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
Role of oxidative stress in the efficacy and toxicity of herbal supplements
Gabriel Tao et al.
CURRENT OPINION IN TOXICOLOGY (2020)
Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis
Yuxi Li et al.
SYSTEMATIC REVIEWS (2020)
Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
Christin Mueller et al.
ANTIVIRAL RESEARCH (2018)
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
Daniel Todt et al.
ANTIVIRAL RESEARCH (2018)
Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms
Wei Wang et al.
CARCINOGENESIS (2018)
Virucidal, antiviral and immunomodulatory activities of β-escin and Aesculus hippocastanum extract
Flavia M. Michelini et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2018)
Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein
Ji Yeun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
A Comprehensive Strategy to Evaluate Compatible Stability of Chinese Medicine Injection and Infusion Solutions Based on Chemical Analysis and Bioactivity Assay
Jian-Ping Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
Antiviral escin derivatives from the seeds of Aesculus turbinata Blume (Japanese horse chestnut)
Ji Won Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
Yuewen Ding et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin
Jean K. Millet et al.
ANTIVIRAL RESEARCH (2016)
An analysis of FDA-approved drugs: natural products and their derivatives
Eric Patridge et al.
DRUG DISCOVERY TODAY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
Mi-Sun Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
Martin Michaelis et al.
PHYTOMEDICINE (2011)
Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections
B. Glatthaar-Saalmueller et al.
PHYTOMEDICINE (2011)
The biological potential of flavones
Alok Kumar Verma et al.
NATURAL PRODUCT REPORTS (2010)
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
Tin-Yun Ho et al.
ANTIVIRAL RESEARCH (2007)
Randomized trial of a fixed combination (KanJang®) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections
M Narimanian et al.
PHYTOMEDICINE (2005)
Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
T Mori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Small molecules targeting severe acute respiratory syndrome human coronavirus
CY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
